Page 352«..1020..351352353354..360370..»

This Simple Fish May Have Been One of the First Vertebrates – The Scientist

Posted: July 11, 2022 at 2:00 am

Artist's rendition of a yunnanozoan, highlighting its basketlike pharyngeal arches

DINGHUA YANG

More than 500 million years ago, as myriad new lifeforms were emerging and diversifying in the worlds oceans, a small, wormlike fish called the yunnanozoan (Yunnanozoan livitidum) flourished around what is now southwestern China.

Based on the numerous fossils that have been found, this sea creature seemingly had little more to it than eyes, a rudimentary brain, and a basketlike skeleton of cartilage supporting its digestive tract. Yet as with many other organisms that emerged during this time, paleontologists have long known that yunnanozoans represent important developments in evolutionary history, especially regarding the emergence of the skeleton and, eventually, the spine. Despite this, yunnanozoans classification has been controversial among researchers for years, explains Nanjing University paleontologist Baoyu Jiang, as experts have interpreted various parts of its anatomy as evidence that it belonged to different ancient clades. Now, research by Jiang and his colleagues published today (July 7) in Scienceconcludes that yunnanozoans may be among the earliest vertebrates.

Vertebrates are thought to have emerged during the Cambrian explosion around 520 million years ago, but the point in time at which these animals branched away from the phylum of chordata, which lack the rigid structures that protect vertebrates nervous system, is difficult to pin down. Over the years, numerous hypotheses for how vertebrates first appeared and developed have emerged, Jiang tells The Scientist. Any progress about the [yunnanozoans] phylogenetic position is key to understanding the origin of vertebrates, he says, so the researchers decided to apply newer imaging techniques to 127 recently collected yunnanozoan fossils in order to determine how best to classify the animals and how to place them within evolutionary history.

In the past, various researchers have placed yunnanozoans into multiple clades, including cephalochordates (a clade of rudimentary invertebrate marine animals), hemichordates (considered to be a link between invertebrates and vertebrates), and even in a far more ancient group called the stem deuterostomes. These conflicting designations tend to be based on observations of the same fossils, with researchers disagreeing on how to interpret various structures.

In the new study, the team examined the fossils with X-ray computed microtomography (micro-CT) and scanning electron microscopytwo techniques that Mount Holyoke College paleontologist Mark McMenamin, who didnt work on the study, says have recently become the standard for the field but havent yet been applied to many types of fossils. The researchers focused primarily on seven pairs of symmetrical arches that are thought to be a precursor to modern skeletons, and especially of the head and jaws of vertebrates.

One of the yunnanozoan fossils analyzed in the study

FANGCHEN ZHAO

Jiang and his colleagues found that those arches contain a pattern of filaments, interconnected by bamboo-like bars of cellular cartilage, that closely resemble the gill arches of modern fish and align with earlier predictions for what an early vertebrate ancestor would look like. These structures, overlooked by prior analyses, are typical of a vertebrate, Jiang tells The Scientist, and are missing from fossils of early chordates. The findings, he says, support the hypothesis that vertebrates heads and jaws did indeed develop from the first two arches found in yunnanozoans and similar organisms.

The arches structure, the authors say, also resembles the modern vertebrates pharyngeal skeletonswhich develops from three embryonic germ layers and neural crest cellsand provide important details regarding when in evolutionary history these skeletons emerged. Collectively, they write, the arches features suggest that yunnanozoans may be stem (early) vertebrates.

What makes this exciting is not so much the actual old age of the fossils, but [the] placement of the yunnanozoans on the phylogenetic tree, David Jandzik, an evolutionary biologist at Comenius University in Slovakia and the University of Colorado Boulder who didnt work on the study, tells The Scientist over email. Yunnanozoans had been (controversially) placed among stem vertebrates before, and it is not surprising that the new details on fossil morphology can lead to dramatic changes in the topology of a phylogenetic treewhich is basically a hypothesis on who is more closely related to whom.

The finding that yunnanozoan pharyngeal arches are homologous to those of vertebrates suggests that yunnanozoans belong among vertebrates rather than chordates, Jandzik explains, and the paper shows that [an] elaborate pharyngeal skeleton composed of cellular cartilage might have existed earlier [than previously assumed] and that its evolution was probably even more rapid than we had thought before.

Jandzik notes that reclassifications of this sort happen all the time due to the incompleteness and imperfect preservation of the fossil material, but says that the authors conclusion that yunnanozoans are vertebrates may be difficult to topple. The new material presented in this study is relatively robust, he says, so it might require even more compelling new evidence.

McMenamin says he found the papers claim that the yunnanozoan fossils presently contain the earliest evidence of a pharyngeal skeletonwhich served as the foundation of the skeletons of the vertebrates still alive today and gave rise to structures such as the head and jawparticularly compelling. If their interpretation that yunnanozoans are vertebrates are correct, that pushes the origins of vertebrates into the early Cambrian, he says, as yunnanozoan fossils predate the time vertebrates were thought to have first evolved, and it will expand our notion of the diversity of form very early in the history of these creatures.

However, McMenamin says hes not completely convinced that interpretation is correct. He points out that the fossils seem to be missing a notochorda rod typically found behind the neural tube in chordates, which provides structural support and assists in the patterning of cells into tissues during embryonic development. This structure is flexible in chordates but stiffer in vertebrates, and McMenamin says he would have expected it to have been preserved in fossils across hundreds of millions of years better than the arches identified in the paper, had it been present in yunnanozoans. The absence of a notochord, he says, is one factor that has allowed for the many interpretations of yunnanozoan phylogeny, and therefore he says it was a little bit of a surprise to see the fish definitively classified as a vertebrate, rather than a chordate, without one.

I think [the authors] made good advances in the imaging, and their interpretation of these structures is reasonable, but I dont think theyve knocked down the controversy of the affinity of the yunnanozoans, McMenamin says.

Jiang says that there was some evidence of a physical groove in the fossils where a notochord would be expected, potentially indicating its presence, but that he and his colleagues didnt mention it in the paper because in this study, we focused on the arches.

Despite his reservations about the notochord, I would just say that this is a very welcome techniques paper that is adding new data to the mix, McMenamin tells The Scientist, adding that it is going to really help us understand early chordateand possibly as well early vertebrateevolution.

Go here to read the rest:
This Simple Fish May Have Been One of the First Vertebrates - The Scientist

Posted in Colorado Stem Cells | Comments Off on This Simple Fish May Have Been One of the First Vertebrates – The Scientist

Internet of Nano Things Market is Poised to Grow at a CAGR of 24.12% during the Forecast Period of 2022-2031 – Digital Journal

Posted: July 11, 2022 at 1:57 am

The Internet of Nano Things Market was valued at USD 9.90 billion in 2019 and is expected to reach USD 36.17 billion by 2025, at a CAGR of 24.12% over the forecast period 2022 2031. The internet of nano things is very much similar to the internet of technology in which the devices that are interconnected with IoNT are miniaturized.

The development of nano-machines with communication capabilities and interconnection with micro- and macro-devices will empower IoNT, which is being increasingly seen as the next major innovation in technology. These devices have dimensions ranging from 1 nm to 100 nm, and are interconnected with classical networks leading to new networking paradigms.

The increased government spending in the aerospace and defence sector is expected to drive the IoNT market for the forecast period as IoNT recently has found major applications in the fields of Nano-drones that could be used for monitoring and carrying explosives sufficient enough that penetrates the targeted subject.

The world economic forum in 2016, released the list of top 10 emerging technologies in which nano-sensors and nanotechnology were ranked first. As the integration of the nanotechnology in various industries increases, it would increase the dependence on IoT as a platform for nanodevices which would boost the IoNT market positively.

However huge capital investment required for the development of nanotechnology is a factor that could hinder the growth of the IoNT market.

Scope of the Report

The Interconnection of nanoscale devices with existing communication networks and ultimately the Internet defines a new networking paradigm called Internet of Nano-Things. This report segments the market by Device (Nano Cameras, Nano Phones, Nanosensors, Nano Processors, Nano-Memory Cards, Nano Power Systems, Nano-Antennas, Nano Transceivers), End-user (Healthcare, Logistics, Media & Entertainment, Telecom & IT, Defense & Aerospace, Manufacturing, Energy & Power, Retail), and Geography.

Download PDF Sample Report [emailprotected] https://www.sdki.us/sample-request-80865

Key Market Trends

Healthcare Industry is Expected to Hold a Significant Share

The expectations of a better quality of life coupled with the aging population and the changing lifestyles have resulted in an increase in demand for more efficient and affordable and improved healthcare.

For instance, Cambridge University nanotech researchers collaborated with a US insurer and other corporate players to explore the commercial potential of an intelligent lavatory that captures massive amount of key data in users urine which could then be used for the timely and effective delivery of the personalized medicines.

The development of nanomedicine which uses properties of a material developed on a nanoscale offering the potential to cross natural barriers and access new sites of delivery. This nanometric size allows interaction with the DNA or small proteins at different levels in the blood or within organs, tissues, and cells.

With advancements in the fields of nanotechnology has allowed in the detection of diseases in very minute amounts or in the initial stages. For instance, in April 2019, a pair of NJIT inventors Bharath Babu Nunna and Eon Soo Lee has been instrumental in developing nanotechnology enhanced biochip to detect cancers, malaria and viral diseases such as pneumonia early in their progression with a pinprick blood test.

With increased spending on healthcare by emerging and developed economies is expected to boost the investment in the fields of IoNT which would influence the market positively.

North-America is Expected to Hold the Largest Share

Various harmful diseases are proving to be a tremendous challenge for modern medicine. This, coupled with growing consumer health awareness in the region, means for more advanced technology. Nano medicine was introduced in this industry to overcome this hurdle since it offers a number of potential ways to improve medical diagnosis & therapy, even in regenerating tissues and organs.

Nanomaterials have been instrumental in improving a bodys acceptance of transplants, artificial bone materials, and other implanted medical devices. For instance, in 2016, the US Department of Health and Human Services invested USD 500 million for the development of medical devices containing nanomaterials.

Access Free Sample Report With Graphs and [emailprotected] https://www.sdki.us/sample-request-80865

Various companies have been instrumental in developing devices that drastically helps the person to improve breathing especially for asthma and allergy sufferers. For instance, Molekuiles Air purifier that was developed by Dr. Goswami, the Director of the University of South Floridas Clean Energy Research Center uses brand new nanotechnology that is far superior to the HEPA air filters.

Competitive Landscape

The internet of nano things market is highly competitive and consists of several key players like Schneider Electric, IBM, Intel and many more. However, the market remains consolidated with many players trying to occupy the share. Their ability to continually innovate their products and services by investing significantly in research and development has allowed them to gain a competitive advantage over other players.

About Us

SDKI Incgoal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

Contact Us

Lauren Brown

600 S Tyler StSuite 2100 #140AMARILLO, TX 79101Email:[emailprotected]

Go here to see the original:
Internet of Nano Things Market is Poised to Grow at a CAGR of 24.12% during the Forecast Period of 2022-2031 - Digital Journal

Posted in Nano medicine | Comments Off on Internet of Nano Things Market is Poised to Grow at a CAGR of 24.12% during the Forecast Period of 2022-2031 – Digital Journal

Nanomedicine in Central Nervous System Injury and Repair Market Share, Regional Growth Analysis, Upcoming Trends, Growth Factors and Leading…

Posted: July 11, 2022 at 1:57 am

A reliable Nanomedicine in Central Nervous System Injury and Repair Market report has been organized with the contributions from a group of specialists in view of definite market examination. This market report has bits of knowledge about market definition, orders, applications, and commitment. The business report additionally incorporates notable information, present market patterns, climate, mechanical advancement, impending advances, and the specialized advancement in the connected business. By considering heap of targets of the showcasing research, this report has been produced. A worldwide statistical surveying report displays significant item improvements and tracks late acquisitions, consolidations, and exploration in the business by the top market players.

At the point when a boundless market overview report is there in the image, organizations can accomplish definite market experiences with which acquiring commercial center plainly into the center turns out to be simple. This business report covers central participants methodologies that basically comprise of new item dispatches, extensions, arrangements, joint endeavors, organizations, acquisitions, and others that advance their impressions in the business. It additionally illuminates about the moving development and business approaches. With the top notch report, organizations can find out about how the market will act in the conjecture a long time with justifiable insights regarding market definition, orders, applications, and commitment.

The nanomedicine in central nervous system injury and repair market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 51,419.82 million by 2028 and grow at a CAGR of 9.91% in the above-mentioned forecast period. Increase in the prevalence of central nervous system diseases such as Parkinsons disease, senile dementia, Alzheimer disease, ocular diseases among others drives the nanomedicine in central nervous system injury and repair market.

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nanomedicine-in-central-nervous-system-injury-and-repair-market

Major Players:-

The major players covered in the nanomedicine in central nervous system injury and repair market report are Abbott, Ablynx N.V, California Life Sciences Association, CELGENE CORPORATION, Teva Pharmaceutical Industries Limited, GENERAL ELECTRIC COMPANY, Merck Sharp & Dohme Corp (a subsidiary of Merck & Co., Inc), Pfizer Inc, Nanosphere Inc, Johnson & Johnson Private Limited and BD among other domestic and global players.

Competitive Landscape and Nanomedicine in Central Nervous System Injury and Repair Market Share Analysis

The nanomedicine in central nervous system injury and repair market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to nanomedicine in central nervous system injury and repair market.

Nanomedicine is defined as the nanotechnology which is used for treating, diagnosing, preventing diseases and traumatic injury, and to control of human biological systems using engineered nanodevices and nanostructures at the molecular level. Nanomedicine uses nano-tools that are 1000 times smaller than a cell for treatment of single cell and is also used in polymer therapeutics, regenerative medicine and targeted drug delivery.

Rise in the awareness related to nanomedicine applications is the vital factor escalating the market growth, also rise in thegovernmentfocus in terms of high funding for life science research and technological advancements in manufacturing process of nanomedicine, increase in the use of nanomedicine as probe or contrast agent in medical imaging techniques to extend the application of imaging and to improve the quality of images and rise in the healthcare expenditures are the major factors among others driving the nanomedicine in central nervous system injury and repair market. Moreover, rise in the technological advancements and modernization in the healthcare devices and rise in the risingresearch and developmentactivities in the healthcare sector will further create new opportunities for nanomedicine in central nervous system injury and repair market in the forecasted period of 2021-2028.

For More Insights Get FREE Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-nanomedicine-in-central-nervous-system-injury-and-repair-market

However, high cost associated with nanomedicine based devices, rise in the stringent government regulations and increase in the risk of environment contamination due to release of toxic nanomaterials are the major factors among others which will obstruct the market growth, and will further challenge the growth of nanomedicine in central nervous system injury and repair market in the forecast period mentioned above.

This nanomedicine in central nervous system injury and repair market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nanomedicine in central nervous system injury and repair market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Nanomedicine in Central Nervous System Injury and Repair Market Scope and Market Size

The nanomedicine in central nervous system injury and repair market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

The nanomedicine in central nervous system injury and repair market is also segmented on the basis ofapplicationinto clinical oncology, infectious diseases, clinical cardiology, orthopedics and others.

Nanomedicine in Central Nervous System Injury and Repair Market Country Level Analysis

The nanomedicine in central nervous system injury and repair market is analysed and market size insights and trends are provided by product and application as referenced above.

The countries covered in the nanomedicine in central nervous system injury and repair market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nanomedicine in central nervous system injury and repair market due to rise in the presence of technologically advanced healthcare infrastructure in this region. Asia-Pacific is the expected region in terms of growth in nanomedicine in central nervous system injury and repair market due to rise in the awareness about nanomedicine and high prevalence of chronic diseases in countries in the region.

The country section of the nanomedicine in central nervous system injury and repair market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The nanomedicine in central nervous system injury and repair market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for nanomedicine in central nervous system injury and repair market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nanomedicine in central nervous system injury and repair market. The data is available for historic period 2010 to 2019.

Read More @ https://www.databridgemarketresearch.com/reports/global-nanomedicine-in-central-nervous-system-injury-and-repair-market

Customization Available: Global Nanomedicine in Central Nervous System Injury and Repair Market

Data Bridge Market Researchis a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @Corporatesales@databridgemarketresearch.com

Excerpt from:
Nanomedicine in Central Nervous System Injury and Repair Market Share, Regional Growth Analysis, Upcoming Trends, Growth Factors and Leading...

Posted in Nano medicine | Comments Off on Nanomedicine in Central Nervous System Injury and Repair Market Share, Regional Growth Analysis, Upcoming Trends, Growth Factors and Leading…

Eggshell and bioceramics: Break an egg to fix a tooth or two – BusinessLine

Posted: July 11, 2022 at 1:57 am

If the stakeholders play it right, we could see the birth of a new industry whose essential raw material is something that is dumped as waste eggshells.

In recent years, the scientific community has been discovering the usefulness of eggshells in making bioceramics materials used to repair bones and teeth. Eggshells, non-toxic and plentifully available at practically no cost, are rich in calcium carbonate, which can be converted into a variety of calcium phosphates, the basic building material of bones and teeth. Recent research by Prof TS Sampath Kumar of the Medical Materials Laboratory, Department of Metallurgical and Materials Engineering, Indian Institute of Technology, Madras, identifies several pathways for the use of eggshell-derived chemicals in medicine as bone fillers, dental fillers, cements and drug delivery systems.

This is of particular interest to India, home to the worlds third largest poultry sector, where 730 million birds lay about 120 billion eggs a year roughly, 600,000 tonnes of eggshells. Kumar calls it a gold mine.

His research, published in the Journal of the Indian Institute of Science, tried to find out why eggshells are so suited to be made into bioceramics. When a doctor injects a paste into a fractured bone, it is expected to bond with the bone environment and become a part of it. Basic chemistry tells us that any bonding involves the attraction of ions, which are atoms that have more electrons than protons (negatively charged) or fewer (positively charged). So, proper bonding calls for the presence of ions. Bones have tiny amounts of magnesium, strontium, silicon and sodium. Kumars research showed that eggshells, too, have these. In fact, without these, the birds couldnt have made the eggs in the first place.

Eggshells are made up of calcium carbonate (94 per cent), calcium phosphate (1 per cent) and other organic matter (4 per cent). Calcium phosphates (CaPs) have been known to be good bone substitutes. Among the various CaPs, hydroxyapatite (HA) and its variant, calcium-deficient hydroxyapatite (CDHA), are known to help bone healing and bone regeneration.

Kumars Medical Materials Laboratory is tucked away in a nondescript, tiled shed that once used to house electrical generators. It has none of the glitzy sophistication of a buzzing chemical research centre. But, as it turns out, the researchers here didnt need anything more than a ream of writing paper and a microwave oven.

Using the microwave oven, Kumar and his team (comprising K Madhumathi and R Jayasree) synthesised HA and CDHA from cleaned chicken eggshells. (Eggshells were heated to 900 degrees C for three hours to convert calcium carbonate into calcium oxide, which, in turn, becomes calcium hydroxide on exposure to air. Adding diammonium hydrogen phosphate to this yielded nano CDHA).

The process was novel it was indeed a sort of cooking, with eggshells and phosphoric acid. The team was also able to tune the CDHA to vary the ratio of calcium to phosphorous for application-specific compositions.

While CDHA is a sort of flagship product, the team came up with a bunch of other products too. For example, they heated HA to 1,100 degrees C, and came up with tricalcium phosphate (TCP). Heat HA to 1,400 degrees C, you get tetra-calcium phosphate (TTCP), an excellent material for making cement to fix broken bones.

Further, any material that is introduced into the skeletal system to fill gaps or build back bones or gum together broken bones should ideally be capable of conducting drugs to wherever they are required. For example, if there is a bone infection, the man-made material should be a good drug carrier. Kumar says eggshell-derived materials are good at this too. It is not difficult to synthesise calcium phosphate in nano form. Nano materials distribute drugs well. Calcium phosphate nanoparticles offer more reaction sites for drug binding due to their high surface-to-volume ratios compared with bulk form. The researchers found out that eggshell-derived nano CDHA, tuned to a calcium-to-phosphate ratio of 1.61, was best suited for delivery of antibiotics, while eggshell-derived TCP was best for ibuprofen loading.

Thus, the team was able to produce a phalanx of products from eggshells, such as HA, CDHA (with variable calcium-to-phosphate ratios), carbonated apatite, amorphous calcium phosphate, TCP and TTCP, to suit specific medical applications. Kumar stressed that many more products could be derived from eggshells any calcium-based product. For example, carbonated apatite, a good cancer fighter, can be produced from eggshells.

It is pertinent to note that calcium phosphates have always been used for bioceramics. Whats new is that it can be made from eggshells. Kumar notes that people generally keep away from natural raw materials because they are non-homogenous. For instance, different eggshells from different parts of the country could have varying properties. The solution is to procure eggshells from a single source. On the other hand, eggshell-based bioceramics are better than synthetic bioceramics because they contain ions of magnesium, strontium, silicon and sodium. The various ions present in eggshell can not only play a key role in bone regeneration but also influence the binding of therapeutic molecules like proteins and drugs, Kumar says.

He says that the research is at a technology readiness level of 4 (TRL-4), which means it is ripe for the industry to scale it up. Further, the use of eggshells is still under-explored there would be many more specific applications. For example, 3D bioprinting with eggshell-derived biomaterials could lead to the fabrication of more functional tissues and organs.

One should also not forget the role of this eggshell-derived bioceramics in the circular economy. Indiscriminate disposal of eggshells leads to microbial contamination, a harm that we hardly take notice of. A push from the government towards collection of eggshells would be a big help, Kumar says.

Published onJuly 10, 2022

Link:
Eggshell and bioceramics: Break an egg to fix a tooth or two - BusinessLine

Posted in Nano medicine | Comments Off on Eggshell and bioceramics: Break an egg to fix a tooth or two – BusinessLine

Notable Thermal and Mechanical Properties of New Hybrid Nanostructures – AZoM

Posted: July 11, 2022 at 1:57 am

Carbon-based nanomaterials such as carbon nanotubes (CNTs), fullerenes, and graphene receive a great deal of attention today due to their unique physical properties. A new study explores the potential of hybrid nanostructures and introduces a new porous graphene CNT hybrid structure with remarkable thermal and mechanical properties.

Image Credit:Orange Deer studio/Shutterstock.com

The study shows how the remarkable characteristics of novel graphene CNT hybrid structures could be modified by slightly changing the inherent geometric arrangement of CNTs and graphene, plus various filler agents.

The ability to accurately control thermal conductivity and mechanical strength in the graphene CNT hybrid structures make them a potentially suitable candidate for various application areas, especially in advanced aerospace manufacturing where weight and strength are critical.

Carbon nanostructures and hybrids of multiple carbon nanostructures have been examined recently as potential candidates for numerous sensing, photovoltaic, antibacterial, energy storage, fuel cell, and environmental improvement applications.

The most prominent carbon-based nanostructures in the research appear to be CNTs, graphene, and fullerene. These structures exhibit unique thermal, mechanical, electronic, and biological properties due to their extremely small size.

Structures that measure in the sub-nanometer range behave according to the peculiar laws of quantum physics, and so they can be used to exploit nonintuitive phenomena such as quantum tunneling, quantum superposition, and quantum entanglement.

CNTs are tubes made out of carbon and that measure only a few nanometers across in diameter. CNTs display notable electrical conductivity, and some are semiconductor materials.

CNTs also have great tensile strength and thermal conductivity due to their nanostructure, and the strength of covalent bonds formed between carbon atoms.

CNTs are potentially valuable materials for electronics, optics, and composite materials, where they may replace carbon fibers in the next few years. Nanotechnology and materials science also use CNTs in research.

Graphene is a carbon allotrope that is shaped into a single layer of carbon atoms arranged in a two-dimensional lattice structure composed of hexagonal shapes. Graphene was first isolated in a series of groundbreaking experiments byUniversity of Manchester, UK, scientists Andrew Geim and Konstantin Novoselov in 2004, earning them the Nobel Prize for Physics in 2010.

In the few decades since then, graphene has become a useful nanomaterial with exceptionally high tensile strength, transparency, and electrical conductivity leading to numerous and varied applications in electronics, sensing, and other advanced technologies.

A fullerene is another carbon allotrope that has been known for some time. Its molecule consists of carbon atoms that are connected by single and double bonds to form a mesh, which can be closed or partially closed. The mesh is fused with rings of five, six, or seven atoms.

Fullerene molecules can be hollow spheres, ellipsoids, tubes, or a number of other shapes and sizes. Graphene could be considered an extreme member of the fullerene family, although it is considered a member of its own material class.

As well as a great deal of research invested into understanding and characterizing these carbon nanostructures in isolation, scientists are also exploring the properties of hybrid nanostructures that combine two or more nanostructure elements into one material.

For example, foam materials have adjustable properties that make them suitable for practical applications like sandwich structure design, biocompatibility design, and high strength and low weight structure design.

Carbon-based nanofoams have been utilized in medicine as well, examining bone injuries as well as acting as the base for replacement bone tissue.

Carbon-based cellular structures are produced both with chemical vapor deposition (CVD) and solution processing. Spark plasma sintering (SPS) methods are also implemented for using graphene for biological and medical applications.

As a result, scientists have been looking at ways to make three-dimensional carbon foams structurally stable. Research suggests that stable junctions between different types of structures (CNTs, fullerene, and graphene) need to be formed for this material to be stable enough for extensive application.

New research from mechanical engineers at Turkeys Istanbul Technical University introduces a new hybrid nanostructure formed through chemical bonding.

The porous graphene CNT structures were made by organizing graphene around CNTs in nanoribbons. The different geometrical arrangement of graphene nanoribbon layers around CNTs (square, hexagon, and diamond patterns) led to different physical properties being observed in the material, suggesting that this geometric rearrangement could be used to fine-tune the new structure.

The study was published in the journal Physica E: Low-dimensional Systems and Nanostructures in 2022.

Researchers found that the structures with fullerenes inserted, for example, exhibited significant compressive stability and strength without sacrificing tensile strength. The geometric arrangement of carbon nanostructures also had a significant effect on their thermal properties.

Researchers said that these new hybrid nanostructures present important advantages, especially for the aerospace industry. Nanoarchitectures with these hybrid structures may also be utilized in hydrogen storage and nanoelectronics.

Belkin, A., A. Hubler, and A. Bezryadin (2015). Self-Assembled Wiggling Nano-Structures and the Principle of Maximum Entropy Production. Scientific Reports. doi.org/10.1038/srep08323

Degirmenci, U., and M. Kirca (2022). Carbon-based nano lattice hybrid structures: Mechanical and thermal properties. Physica E: Low-dimensional Systems and Nanostructures. doi.org/10.1016/j.physe.2022.115392

Geim, A.K. (2009). Graphene: Status and Prospects. Science. /doi.org/10.1126/science.1158877

Geim, A.K., and K.S. Novoselov (2007). The rise of graphene. Nature Materials. doi.org/10.1038/nmat1849

Monthioux, M., and V.L. Kuznetsov (2006). Who should be given the credit for the discovery of carbon nanotubes? Carbon. doi.org/10.1016/j.carbon.2006.03.019

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

See the original post here:
Notable Thermal and Mechanical Properties of New Hybrid Nanostructures - AZoM

Posted in Nano medicine | Comments Off on Notable Thermal and Mechanical Properties of New Hybrid Nanostructures – AZoM

Nanorobotics Market 2022 Research Report Analysis from Perspective of Segmentation and Industry Growth 2030 Designer Women – Designer Women

Posted: July 11, 2022 at 1:57 am

Key Companies Covered in theNanorobotics MarketResearch areBruker, JEOL, Thermo Fisher Scientific, Ginkgo Bioworks, Oxford Instruments, EV Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnikand other key market players.

Global Nanorobotics Market is valued approximately USD 5.63 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.24% over the forecast period 2020-2027.

Nanorobotics is a type of walk-in clinic that provides ambulatory care in a dedicated medical facility outside of a conventional emergency room (ER). Also, the Nanorobotics is used for treating injuries and illness that need immediate care. The increasing investments in urgent care, increasing geriatric population and strategic development between hospitals and urgent care providers has led the adoption of Nanorobotics across the forecast period.

Request To Download Free Sample of This Strategic Report:https://www.quadintel.com/request-sample/nanorobotics-market-2/QI037

as per the Journal of Urgent Care Medicine in 2017, Hospital Corporation of America has expanded Nanorobotics in an effort to build patient access points in its 14 major markets. Also, the Corporation use a portion of its effort $2.9 billion capital budget in 2017 to increase urgent care locations from 72 to 120 by the year-end. However, high manufacturing costs impedes the growth of the market over the forecast period of 2020-2027. Also, with the increasing prevalence of injuries, the adoption & demand for Nanorobotics is likely to increase the market growth during the forecast period.

The regional analysis of globalNanorobotics marketis considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading/significant region across the world in terms of market share owing to the growing geriatric population and promptness & affordability of urgent care services coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rising disposable income, rising incidences of injuries and improving healthcare infrastructure would create lucrative growth prospects for the Nanorobotics market across Asia-Pacific region.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

Download Free Sample Report, SPECIAL OFFER (Avail an Up-to 30% discount on this report)https://www.quadintel.com/request-sample/nanorobotics-market-2/QI037

The detailed segments and sub-segment of the market are explained below:

By Type:NanomanipulatorBio-NanoroboticsMagnetically GuidedBacteria-Based

By Application:NanomedicineBiomedicalMechanicalOthers

By Region:North AmericaU.S.CanadaEuropeUKGermanyFranceSpainItalyROE

Asia PacificChinaIndiaJapanAustraliaSouth KoreaRoAPACLatin AmericaBrazilMexicoRest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018Base year 2019Forecast period 2020 to 2027

Target Audience of the Global Nanorobotics Market in Market Study:

Key Consulting Companies & AdvisorsLarge, medium-sized, and small enterprisesVenture capitalistsValue-Added Resellers (VARs)Third-party knowledge providersInvestment bankersInvestors

Request full Report Description, TOC, Table of Figure, Chart, etc.@https://www.quadintel.com/request-sample/nanorobotics-market-2/QI037

Table of content

Market OverviewMarket Definition and ScopeMarket DynamicsMarket Industry AnalysisMarket, Regional AnalysisAnalysis of Leading CompaniesCompetitive IntelligenceResearch ProcessMarket Analysis and Forecast, By Product Types

What is the goal of the report?

The market report presents the estimated size of the Market at the end of the forecast period. The report also examines historical and current market sizes. During the forecast period, the report analysis the growth rate, market size, and market valuation. The report presents current trends in the industry and the future potential of the North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa markets. The report offers a comprehensive view of the market based on geographic scope, market segmentation, and key player financial performance.

What is the key information extracted from the report?

Extensive information on factors estimated to affect the Market growth and market share during the forecast period is presented in the report.The report offers the present scenario and future growth prospects Market in various geographical regions.The competitive landscape analysis on the market as well as the qualitative and quantitative information is delivered.The SWOT analysis is conducted along with Porters Five Force analysis.The in-depth analysis provides an insight into the Market, underlining the growth rate and opportunities offered in the business.

Request Full Reporthttps://www.quadintel.com/request-sample/nanorobotics-market-2/QI037

About Quadintel:

We are the best market research reports provider in the industry. Quadintel believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Quadintel is a one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Quadintel:Email:sales@quadintel.comAddress: Office 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATESTel: +1 888 212 3539 (US TOLL FREE)Website:https://www.quadintel.com/

More here:
Nanorobotics Market 2022 Research Report Analysis from Perspective of Segmentation and Industry Growth 2030 Designer Women - Designer Women

Posted in Nano medicine | Comments Off on Nanorobotics Market 2022 Research Report Analysis from Perspective of Segmentation and Industry Growth 2030 Designer Women – Designer Women

Artificial Intelligence in Medical Diagnostics Market Worth $9.38 Billion by 2029 – Exclusive Report by Meticulous Research – GlobeNewswire

Posted: July 11, 2022 at 1:57 am

Redding, California, July 07, 2022 (GLOBE NEWSWIRE) -- According to a new market research report, Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Ophthalmology), Modality (MRI, CT, X-ray, Ultrasound), End User (Hospital, Diagnostic Center) - Global Forecast to 2029,' published by Meticulous Research, the AI in medical diagnostics market is expected to grow at a CAGR of 36.2% during the forecast period to reach $9.38 billion by 2029.

DownloadFree Sample Report Now @https://www.meticulousresearch.com/download-sample-report/cp_id=5312

AI in medical diagnostics consists of AI software and services that aid healthcare professionals in identifying the diagnosis of different diseases. AI-based software solutions can analyze the data from a diagnostic procedure and either help triage patients by flagging abnormal medical images or suggest the healthcare professional a suitable diagnosis. AI in medical diagnostics integrates deep learning, data insights, and algorithms to detect life-threatening and critical diseases. It automates the diagnosis process and reduces the workload on healthcare professionals.

The main factors driving the AI in medical diagnostics market are the growing need for the adoption of AI in medical diagnosis due to the high rate of errors in medical diagnosis, shortage of healthcare professionals, and increasing prevalence of chronic diseases. Furthermore, the high growth potential in emerging economies and the growing number of cross-industry partnerships & collaborations are expected to provide significant growth opportunities for this market.

However, the reluctance to adopt AI technologies due to a lack of trust is expected to restrain the growth of this market to a notable extent. In addition, factors such as regulatory barriers and privacy and security concerns regarding patient data are the major challenges to the growth of this market.

The Impact of COVID-19 on the Artificial Intelligence in Medical Diagnostics Market

The outbreak of the COVID-19 pandemic in 2020 was a global public health challenge. The number of cases was skyrocketing, and many countries had a huge burden on the health system. The COVID-19 disease mainly affects the lungs of the patients. Hence, cardiothoracic imaging in COVID-19 cases is a common diagnostic practice to identify the severity of the disease. The number of research studies using AI techniques to diagnose COVID-19 rapidly increased in 2020. Many studies were focused on describing the diagnosis of COVID-19 from chest CT images using AI technology. Several studies proved that AI models might be as accurate as experienced radiologists in diagnosing COVID-19.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:https://www.meticulousresearch.com/speak-to-analyst/cp_id=5312

CT scans were identified as the key modality for diagnosing COVID-19 at the onset of the disease. Healthcare professionals identified the severity of the disease from features like shadows over the patients lungs. A single patient had approximately 300 CT images, which took a doctor a lot of time to analyze with the naked eye. Also, radiologists needed to compare with earlier scans, increasing pressure on the healthcare staff. In such situations, AI-based systems can analyze CT images within 20 seconds, with an accuracy rate above 90% (Source: Nature Biomedical Engineering Journal). In addition, UC San Diego Health (U.S.) engineered a new method to expedite the diagnosis of pneumonia, a condition associated with severe COVID-19. This early detection helps doctors quickly triage patients to appropriate levels of care even before the COVID-19 diagnosis is confirmed. In May 2020, Mount Sinai Health System (U.S.) implemented artificial intelligence to analyze COVID-19 patients for rapid diagnosis based on CT scans and patient data. Thus, the advantages offered by AI technology have increased its adoption in medical diagnostics during the pandemic.

The AI in medical diagnostics market is segmented based on component, specialty, modality, end user, and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on component, in 2022, the software segment is estimated to account for the largest share of the AI in medical diagnostics market. The large market share of this segment is attributed to the high demand for AI-based software solutions to deliver a quick and accurate medical diagnosis, the growing number of new software approvals & launches, and the rising shortage of specialists.

Based on specialty, in 2022, the radiology segment is estimated to account for the largest share of the AI in medical diagnostics market. The large market share of this segment is attributed to the growing demand for AI in medical imaging, increasing chronic disorders, an increasing number of new software products for AI in radiology, and the increasing global shortage of radiologists. In addition, the benefits of AI for radiologists in terms of non-interpretive data, such as reducing noise in medical images, creating high-quality images from lower doses of radiation, enhancing magnetic resonance image quality, and automatically assessing image quality, also supports the growth of this segment.

Based on modality, in 2022, the CT-scan segment is estimated to account for the largest share of the overall AI in medical diagnostics market. The large market share of this segment is attributed to the advantages that AI-based solutions offer, such as improved operational efficiency, reduced noise in medical images, and reduced patient backlogs and wait times. Additionally, the increasing patient pool prescribed for CT scans and growing numbers of products specific for CT scans supports the growth of this segment.

Quick Buy Artificial Intelligence in Medical Diagnostics Market Research Report: https://www.meticulousresearch.com/Checkout/76337122

Based on end user, in 2022, the hospitals segment is estimated to account for the largest share of the AI in medical diagnostics market. The large share of this segment is attributed to the increasing number of patients undergoing diagnostics procedures in hospitals, the robust financial capabilities of large hospitals to acquire high-cost AI-based software & services, the growing shortage of physicians, and the outbreak of the COVID-19 pandemic.

Based on geography, in 2022, North America is estimated to account for the largest share of the AI in medical diagnostics market, followed by Europe and Asia-Pacific. Some of the major factors driving the growth of the North American AI in medical diagnostics market include technological developments, increasing number of new product approvals, a high adoption rate of AI in healthcare, the presence of key market players, and established IT infrastructure in the healthcare sector. However, Asia-Pacific is slated to register the highest growth rate in the AI in medical diagnostics market during the forecast period. The high market growth in Asia-Pacific is attributed to the high growth opportunity due to the increasing prevalence of various chronic & infectious diseases, the increasing number of AI-based startups, especially in China and India, increasing funding, and a large potential of AI in addressing the gap in the healthcare infrastructure in the region

The report also includes an extensive assessment of the component, specialty, modality, end user, and geography, and key strategic developments adopted by leading market participants in the industry over the past four years (20192022). In recent years, the AI in medical diagnostics market has witnessed numerous product launches, approvals, agreements, collaborations, partnerships, and acquisitions.

The key players profiled in this market study are Siemens Healthineers AG (Germany), GE Healthcare (U.S.), Aidoc Medical Ltd. (Israel), International Business Machines Corporation (U.S.), AliveCor, Inc. (U.S.), VUNO Inc. (South Korea), Digital Diagnostics Inc. (U.S.), NovaSignal Corp. (U.S.), Riverain Technologies (U.S.), NANO-X IMAGING LTD (Israel), Imagen Technologies (U.S.), Koninklijke Philips N.V. (Netherlands), Agfa-Gevaert Group (Belgium), HeartFlow, Inc. (U.S.), and Arterys Inc. (U.S.).

To gain more insights into the market with a detailed table of content and figures, click here:https://www.meticulousresearch.com/product/artificial-intelligence-in-medical-diagnostics-market-5312

Scope of the Report:

Artificial Intelligence in Medical Diagnostics Market, by Component

Artificial Intelligence in Medical Diagnostics Market, by Specialty

Artificial Intelligence in Medical Diagnostics Market, by Modality

Artificial Intelligence in Medical Diagnostics Market, by End User

Artificial Intelligence in Medical Diagnostics Market, by Geography

Request Free Customization of Report @https://www.meticulousresearch.com/request-customization/cp_id=5312

Related Reports:

Healthcare Artificial Intelligence Market by Product and Services (Software, Services), Technology (Machine Learning, NLP), Application (Medical Imaging, Precision Medicine, Patient Management), End User (Hospitals, Patients) - Global Forecast to 2027

https://www.meticulousresearch.com/product/healthcare-artificial-intelligence-market-4937

Medical Image Management Market by Product {PACS [Departmental (Radiology, Mammography, Cardiology), Enterprise], VNA [(On-premise, Hybrid), [Vendor (PACS, Independent Software, Infrastructure)], AICA, Universal Viewer} and End User Global Forecast to 2027

https://www.meticulousresearch.com/product/medical-image-management-market-4761

Precision Medicine Software Market by Deployment Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) - Global Forecast to 2028

https://www.meticulousresearch.com/product/precision-medicine-software-market-5011

About Meticulous Research

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:Mr.Khushal BombeMeticulous Market Research Inc.1267WillisSt,Ste200 Redding,California,96001, U.S.USA: +1-646-781-8004Europe : +44-203-868-8738APAC: +91 744-7780008Email-sales@meticulousresearch.comVisit Our Website:https://www.meticulousresearch.com/Connect with us on LinkedIn-https://www.linkedin.com/company/meticulous-researchContent Source: https://www.meticulousresearch.com/pressrelease/538/artificial-intelligence-in-medical-diagnostics-market-2029

Read more here:
Artificial Intelligence in Medical Diagnostics Market Worth $9.38 Billion by 2029 - Exclusive Report by Meticulous Research - GlobeNewswire

Posted in Nano medicine | Comments Off on Artificial Intelligence in Medical Diagnostics Market Worth $9.38 Billion by 2029 – Exclusive Report by Meticulous Research – GlobeNewswire

Orthobiologics Market is Predicted to Expand at a CAGR of 4.7% during the Forecast Period, notes TMR Study – GlobeNewswire

Posted: July 11, 2022 at 1:57 am

Wilmington, Delaware, United States, July 04, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc.: The value of the global orthobiologics market was clocked at US$ 5.01 Bn in 2021. The orthobiologics marketoutlook predicts the market to rise at a CAGR of 4.7% during the forecast period, from 2022 to 2031. The global orthobiologics market is expected to attain a value surpassing US$ 7.4 Bn by 2031. Until afew years ago, orthobiologics have been a common practice in sports medicine andorthopedic surgeries. Demand analysis of orthobiologics estimates that developments in regenerative medicine, an increasing number of sports andsports-relatedinjuries, rising demand for less invasive procedures, andconstant infusion of innovative products and treatmentsare all expected to propel the global orthobiologics market.

Musculoskeletal tissue engineering and regenerative medicineresearch, however, have slowed down as a result of the COVID-19 outbreak. However,strong development potential in developing nations and a rise in demand for cutting-edge therapies are expected to create considerable prospects for companies in the growth of the orthobiologics market.

The global orthobiologics market is being driven by the increase in orthobiologics product and usage oforthopedic device. In addition to that, there is increasingincorporation of biochemistry andbiology in the treatment of soft tissue andbone injuries. Orthobiologic drugs help natural healing mechanism of the bodyto workmore quickly. They can hasten the healing of injured ligaments, tendons, andmuscles. It alsoassistsin repairing osteoarthritis damage. The materials used to develop orthobiologics are those that are normally present in the human body.

Request Brochure of Orthobiologics Market Research Report https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1747

Key Findings of Market Report

Request for Analysis of COVID-19 Impact on Orthobiologics Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1747

Global Orthobiologics Market: Growth Drivers

Get Exclusive PDF Sample Copy of Orthobiologics Market Report https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1747

Global Orthobiologics Market: Key Players

Some of the key market players are

Make an Enquiry Before Buying https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1747

Global Orthobiologics Market: Segmentation

Product Type

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Stem Cells Market: The global stem cells market is expected to reach the value of US$ 25.68 Bn by the end of 2028.It is estimated to expand at a CAGR of 10.4% from 2021 to 2028.

Placental Stem Cell Therapy Market: The placental stem cell therapy market stood at US$ 0.5 Bn in 2019 and is expected to cross a revenue of US$ 4.4 Bn by the end of 2030.

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market: The global platelet rich plasma & stem cell alopecia treatment market is expected to reach a value of approximately US$ 450.5 Mn by the end of 2026, expanding at a high single digit CAGR during the forecast period.

Soft Tissue Allografts Market: The global soft tissue allografts market was valued at US$ 3.55 Bn in 2018, and is projected to reach ~ US$ 6.2 Bn by 2027, expanding at a CAGR of ~ 6.5% from 2019 to 2027.

Bone Growth Stimulators Market: The global bone growth stimulators market is anticipated to reach more than US$ 2 Bn by the end of 2031. The global market is projected to grow at a CAGR of 5.8% from 2022 to 2031.

Small Bone and Joint Orthopedic Devices Market: The global small bone and joint orthopedic devices market was valued at US$ 5.5 Bn in 2018 and is anticipated to expand at a CAGR of 6.3% from 2019 to 2027.

Metastatic Bone Disease Market: The global metastatic bone disease market was valued at US$ 12,450.0 Mn in 2017 and is anticipated to reach US$ 24,886.8 Mn by 2026, expanding at a CAGR of 8.1% from 2018 to 2026.

Bone Grafts and Substitutes Market: The global bone grafts and substitutes market is expected to cross the value of US$ 4.4 Bn by the end of 2028. It is estimated to expand at a CAGR of 4.9% from 2021 to 2028.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit BhiseyTransparency Market Research Inc.CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USATel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Website:https://www.transparencymarketresearch.comBlog:https://tmrblog.comEmail:sales@transparencymarketresearch.com

Read the original:
Orthobiologics Market is Predicted to Expand at a CAGR of 4.7% during the Forecast Period, notes TMR Study - GlobeNewswire

Posted in Delaware Stem Cells | Comments Off on Orthobiologics Market is Predicted to Expand at a CAGR of 4.7% during the Forecast Period, notes TMR Study – GlobeNewswire

Cell Line Development Market: Increase in Prevalence of Cancer and Other Chronic Diseases to Drive the Market – BioSpace

Posted: July 11, 2022 at 1:57 am

Wilmington, Delaware, United States, Transparency Market Research Inc.: Cell line development is an important technology in life sciences. Stable cell lines are used for various applications including monoclonal antibody and recombinant protein productions, gene functional studies, and drug screening

Read Report Overview - https://www.transparencymarketresearch.com/cell-line-development-market.html

Manual screening method is a traditional method used for cell line development. This method is tend to be disadvantageous as it is labor-intensive and time-consuming. Automation in tools used for cell line development is likely to replace manual methods of cell line development.

Cell line development and culturing is being rapidly adopted in areas of biological drug developments for various chronic diseases, regenerative medicines such as stem cells & cell-based therapies, recombinant protein, and other cellular entities for pharmaceuticals, diagnostics, and various other industries.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75773

Key Drivers and Opportunities of Global Cell Line Development Market

Rise in focus on research & development, owing to increase in prevalence of cancer and other chronic diseases is anticipated to drive the market. Several institutes, such as Cancer Research Institute, National Cancer Institute, Advanced Centre for Treatment, Research and Education in Cancer (Cancer Research Centre [ICRC]), and NCI Community Oncology Research Program (NCORP), are engaged in research & development for cancer diagnosis and treatment. Hence, the initiative of government and non-government organizations is likely boost the growth of the market.

Mammalian cell lines are widely used as production tools for various biologic drugs. Technological advancement in cell line development in mammalian cell culturing is likely to fuel the growth of the market. For instance, according to an article published in Pharmaceuticals (Basel), the U.S. Food and Drug Administered approved 15 novel recombinant protein therapeutics from 2005 to 2011 on an average.

Advances in bioinformatics and recombinant technologies have led to development of new cell lines for synthesis or production of essential peptides, enzymes, saccharides, and other molecules which are being used in pharmaceuticals and various other industries.

Request for Analysis of Cell Line Development Market Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75773

North America to Capture Major Share of Global Cell Line Development Market

North America is expected to account for major share of the global cell line development market due to well-established health care infrastructure and rise in government initiatives. Furthermore, adoption of innovative technologies is likely to augment the market in the region.

The cell line development market in Asia Pacific is expected to grow at a rapid pace during the forecast period, owing to increasing risk of communicable diseases, cancer, and chronic & rare diseases and surge in geriatric population. For instance, according to an article published in BioMed Central Ltd, in 2018, 2.9 million cancer deaths occurred and 4.3 million new cancer cases were recorded in China.

Key Players Operating in Global Cell Line Development Market

The global cell line development market is highly concentrated due to the presence of key players. A large number of manufacturers hold major share in their respective regions. Key players engaged in adopting new strategies are likely to drive the global cell line development market. Key players are developing new, cost-effective biologic products. This is anticipated to augment the market.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=75773

Major players operating in the global cell line development market are:

More Trending Reports by Transparency Market Research

Surgical Retractors Market: Surgical Retractors Market (Product Type: Hand-held Retractors, Self-retaining Retractors, Table-mounted Retractors, and Others; Application: Abdominal Surgeries, Cardiothoracic Surgeries, Orthopedic Surgeries, Obstetric & Gynecological Surgeries, and Others; and End User: Hospitals, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Dental Consumables Market: Dental Consumables Market (Product - Dental Implants, Crowns and Bridges, Dental Biomaterials, Orthodontics, Endodontics, Periodontics, Retail Dental Care Essentials, and Dental Consumables) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Vascular Stents Market: Vascular Stents Market (Type: Coronary Artery Stents, Peripheral Vascular Stents, and Neurovascular Stents; Delivery Method: Balloon Expandable Stents and Self-expanding Stents; Material: Cobalt-Chromium Stent, Platinum-Chromium Stent, Nitinol Stent, Stainless Steel Stent, and Bioresorbable Polymer Stent; End User: Hospitals, Cardiac Centers, and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Monopolar Electrosurgery Market: Monopolar Electrosurgery Market (Product Type - Hand Instruments, Electrosurgical Generator, Return Electrode (Single Use and Re-usable), Accessories (Footswitches and Connectors); Application - General Surgery, Gynecology Surgery, Cardiovascular Surgery, Cosmetic Surgery, Orthopedic Surgery, and Urology Surgery; End User: Hospitals, Ambulatory Surgical Centers, and Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Vertebroplasty and Kyphoplasty Market: Vertebroplasty and Kyphoplasty Market (Product - Vertebroplasty (Needles, Cement Mixing and Delivery Devices), Kyphoplasty (Needles, Balloons, Cement Mixing and Delivery Devices); End use - Hospitals, Ambulatory Surgery Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Air Bubble Detectors Market: Air Bubble Detectors Market (Product Type: Fixed Detectors and Flexible Detectors; Technology: Ultrasonic Sensors and Capacitive Sensors; Application: Dialysis & Transfusion, Cardiopulmonary Bypass, Infusion & Parenteral Infusion Pumps, Diagnostic Devices, Blood Processing Equipment, and Others; and End User: Hospitals & Healthcare Providers, Diagnostic Laboratories, and Pharmaceuticals & Biotechnology Industries) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Refurbished Medical Equipment Market: Refurbished Medical Equipment Market (Product: Medical Imaging Equipment, Operating Room Equipment, Patient Monitoring Devices, and Others; Application: Cardiology, Respiratory and Gastroenterology, Neonatal Care, Orthopedic, and Others; and End User: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Medical Laser Systems Market: Medical Laser Systems Market (Product Type: Gas Lasers, Solid-state Lasers, Fiber Lasers, Diode Lasers, Femtosecond Lasers, and Others; Application: Ophthalmology, Cosmetic/Dermatology, Dentistry, Cancer Therapy, Cardiovascular, and Others; and End User: Hospitals, Ambulatory Surgical Centers, and Specialized Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 2030

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit BhiseyTransparency Market Research Inc.CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USATel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Website: https://www.transparencymarketresearch.comBlog: https://tmrblog.comEmail: sales@transparencymarketresearch.com

See the rest here:
Cell Line Development Market: Increase in Prevalence of Cancer and Other Chronic Diseases to Drive the Market - BioSpace

Posted in Delaware Stem Cells | Comments Off on Cell Line Development Market: Increase in Prevalence of Cancer and Other Chronic Diseases to Drive the Market – BioSpace

Transplant Diagnostic Market: Increase in Number of Cancer & Blood Disorder Patients to Drive the Market – BioSpace

Posted: July 11, 2022 at 1:57 am

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global transplant diagnostic market was valued at US$ 730.9 Mn in 2017 and is projected to expand at a cumulative annual growth rate (CAGR) of 6.6% from 2018 to 2026 according to a new report published by Transparency Market Research (TMR) titled Transplant Diagnostic Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20182026 the report suggests that increase in number of cancer & blood disorder patients and rise in the demand for accurate and cost-effective transplant diagnostic systems is fueling the transplant diagnostic market between 2018 and 2026.

North America and Europe are projected to dominate the global market owing to the increase in demand for efficient and effective management of transplant diagnostic technique and high adoption rate of transplant of organs. The market in Asia Pacific is projected to expand at a prominent growth rate during the forecast period. Expansion of the market in Asia Pacific is attributed to the large base of hospital & transplant centers and research centers, rising number of geriatric population requiring kidney dialysis services, and increasing awareness regarding donation of organs among young generation in the region. The market for transplant diagnostic in Latin America is likely to expand at a moderate growth rate during the forecast period.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20225

Technological assay in transplant diagnostic is expected to fuel global market

The global transplant diagnostic market is projected to be potentially driven by the technological assay offered by various transplant diagnostic companies. Transplant diagnostic provides a wide range of features and benefits such as identification of molecules that are expressed on the cells and are involved in the immune rejection of mismatched grafts and recognition of foreign HLA Class 2 antigens, which makes it more feasible for rapid results in transplantation technique. These features help physicians and nurses to streamline the transplantation activity required for the patients in order to maintain their daily workflow efficiently and effectively.

Key players offering transplant diagnostic are developing value-added features such as real-time PCR technology, PCR-enzyme-linked immunosorbent assay, along with imaging modules, thereby reducing the overall operating cost, which in turn improves the overall effectiveness and efficiency of diagnostic practices. Companies are focusing on the development of PCR-based products and expansion of their operations and increase in their market shares. For instance, in April 2016, Siemens and Thermo Fisher Scientific entered into a partnership, allowing Siemens to integrate Thermo Fisher Scientific's real-time PCR technology in its own technology. These value-added features and advanced assay offers rapid and sensitive detection limit, helping improve the overall duration and quality of diagnostics.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20225

Non-molecular assay is projected to be highly lucrative deployment mode

Non-molecular assays are conventional methods of transplant diagnostic. These assays are employed in developed as well as developing countries in order to detect transplant rejections. Furthermore, these technology-based transplant diagnostic are priced on perpetual license model and are highly priced. Non-molecular assays enable the user to practice antibody-based histocompatibility test that offers low-resolution typing, as compared to molecular assays, and involve culturing together of lymphocytes.

These factors are likely to propel the segment during the forecast period. These non-molecular assay-based techniques addresses specific challenges during identification of the molecules, which expresses on the cells and are involved in the immune rejection of mismatched grafts. The non-molecular assay-based techniques offer rapid results on transplantation and are cost-effective.

Solid organ transplantation application of transplant diagnostic leads the market

The report offers the detailed segmentation of the transplant diagnostic in terms of application into solid organ transplantation and stem cell transplantation. The solid organ transplantation segment is expected to account for a leading share of the market during the forecast period. The factors attributed to the higher share held by the solid organ transplantation segment includes rising incidence of cardiac surgeries, prevalence of kidney related diseases among global population, and the demand for new organs for treatment of cancer by physician and patients. Various reimbursement and Medicare benefits available for patients in treating diseases have led to the high market share held by the solid organ transplantation segment of the global market.

Request for Analysis of COVID-19 Impact on Transplant Diagnostic Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=20225

Hospital & transplant centers segment estimated to dominate the market during the forecast period

In terms of end-user, the hospital & transplant centers segment accounted for a leading share in global transplant diagnostic market. The segment is projected to gain market share by the end of 2026. It is likely to expand at a CAGR more than 7% during the forecast period. Expansion of the conventional serological technique, increasing number of medical facilities from serological assays to genome-based HLA typing for transplant diagnostics, and adoption of large number of donors organs for transplantation practices have led the hospital & transplant centers segment to hold a prominent share of the global transplant diagnostic market.

Increasing number of multinational hospital chains and high digitization budgets are likely to drive the hospital & transplant centers segment during the forecast period. High prevalence and incidence rates of bone injuries, kidney failures, and increase in number of cases of cancer and blood disorder diseases in the global population have led to an increase in patient flow to hospital & transplant centers. These factors are expected to fuel the hospital & transplant centers segment between 2018 and 2026.

Asia Pacific represents potential business development opportunity

North America and Europe accounted for a key share of global transplant diagnostic market in 2017. They are likely to gain market share by the end of 2026. High rate of adoption of transplantation technique for cancer treatment, high submission of healthcare budgets, and government initiatives to promote the donation of organs have contributed to the leading share held by these region in the global transplant diagnostic market. Asia Pacific is projected to be a highly attractive market for transplant diagnostic, and is likely to exhibit a prominent attractiveness index, during the forecast period.

The market in Asia Pacific is projected to expand at a high CAGR of more than 7% during the forecast period. This is due to large number of hospital and transplant centers in emerging economies such as India and China as well as increase in the demand for serological technique-based assays due to their affordability, particularly in developing countries such as China, India, and Malaysia. The market in Latin America is anticipated to expand at a moderate growth rate during the forecast period.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=20225

Key trend of research and development among the leading players to increase geographic presence has been observed in last few years

The report also provides profiles of leading players operating in the global transplant diagnostic market. Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., and Becton, Dickinson and Company are a few leading players operating in the global transplant diagnostic market, which account for significant market share. Companies operating in the transplant diagnostic industry are emphasizing on increasing their geographic presence by means of strategic acquisition and collaboration with leading players in respective domains and geography.

In July 2017, Thermo Fisher Scientific acquired Linkage Biosciences. Linkage Biosciences is presently a part of Thermo Fisher's transplant diagnostics business. Through this acquisition, Thermo Fisher currently provides services to more than 1,000 transplant centers in over 60 countries. Other prominent players operating in the global transplant diagnostic include Ortho Clinical Diagnostics (a part of Carlyle Group), Immucor, Inc., Illumina, Inc., Siemens Healthineers (Siemens AG), and Agilent Technologies .

More Trending Reports by Transparency Market Research

Dry Eye Disease Treatment Market: Dry Eye Disease Treatment Market (Product: Artificial Tears, Anti-inflammatory, Punctal Plugs, Secretagogue, and Others; Disease: Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Alcoholic Hepatitis Therapeutics Market: Alcoholic Hepatitis Therapeutics Market (Treatment: Corticosteroids, Hemorrheologic Agents, Anabolic Steroids, and Others; Application: Mild and Severe/Chronic; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Atipamezole Market: Atipamezole Market (Application: Anti-sedative and Antitoxic [Off-label Use]; Route of Administration: Intramuscular, Intravenous, and Others; Animal Type: Dogs, Cats, and Others; and Distribution Channel: Veterinary Hospitals, Retail Pharmacies, and Online Pharmacies) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Anthelmintic Drugs Market: Anthelmintic Drugs Market (Drug Class: Benzimidazoles, Piperazine, and Others; Route of Administration: Oral and Injectable; Application: Human and Animal; Target Pathogen: Ascaris Lumbricoides [Roundworm], Trichuris Trichiura [Whipworm], Enterobius Vermicularis [Pinworm], Ancylostoma Duodenale [Hookworm], and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, and Veterinary Hospitals & Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Mercury Poisoning Treatment Market: Mercury Poisoning Treatment Market (Drug: Chelating Agents, Combination Therapy with Chelating Agents, and Plasma Exchange Hemodialysis Plasmapheresis; Type: Acute Mercury Poisoning and Chronic Mercury Poisoning; Treatment Type: Supportive Treatment and Antidotal Treatment; Form: Inorganic Mercury, Elemental Mercury, and Organic Mercury; Route of Administration: Injectable and Oral; and Distribution Channel: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Addiction Treatment Market: Addiction Treatment Market (Treatment Type: Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, and Other Substances Addiction Treatment; Drug Type: Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, and Others; Treatment Center: Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers; and Distribution Channel: Hospitals Pharmacies, Medical Stores, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Human Papillomavirus and Cytomegalovirus Therapeutics Market: Human Papillomavirus and Cytomegalovirus Therapeutics Market (Drug Class: Human Papillomavirus Therapeutics and CMV Therapeutics [Ganciclovir/Valganciclovir, Foscavir {Foscarnet}, Cidofovir {Vistide}, Letermovir {Prevymis}, and Others]; Application: Human Papillomavirus Therapeutics and CMV Therapeutics; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Hydrocortisone Market: Hydrocortisone Market (Indication: Adrenocortical Insufficiency, Adrenergic Syndrome, High Blood Calcium, Thyroiditis, Rheumatoid Arthritis, Dermatitis, Asthma and Chronic Obstructive Pulmonary Disease [COPD], and Others; Route of Administration: Parenteral, Oral, Topical, and Rectal; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 2028

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit BhiseyTransparency Market Research Inc.CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USATel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Website: https://www.transparencymarketresearch.comBlog: https://tmrblog.comEmail: sales@transparencymarketresearch.com

See the article here:
Transplant Diagnostic Market: Increase in Number of Cancer & Blood Disorder Patients to Drive the Market - BioSpace

Posted in Delaware Stem Cells | Comments Off on Transplant Diagnostic Market: Increase in Number of Cancer & Blood Disorder Patients to Drive the Market – BioSpace

Page 352«..1020..351352353354..360370..»